MARCKS

Myristoylated alanine-rich C-kinase substrate · P29966 · MARCKS on Sugi Atlas →

0 patent compounds predicted against MARCKS, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to MARCKS by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With Fenofibrate PHASE2/PHASE3WITHDRAWN
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy PHASE2RECRUITING
Doxycycline in Human Pulmonary Tuberculosis PHASE2COMPLETED
Biological Effects of Quercetin in COPD Phase II PHASE2UNKNOWN
Study in Adult Ph-positive ALL PHASE2UNKNOWN
The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients PHASE1/PHASE2WITHDRAWN
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
FAK Inhibitor in Patients With Advanced Solid Tumors PHASE1NOT_YET_RECRUITING
Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma PHASE1COMPLETED
Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101 PHASE1WITHDRAWN
Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212 EARLY_PHASE1COMPLETED
Immune Cell Response to Stimuli nanRECRUITING
Novel Biomarkers in Inflammatory Bowel Disease nanCOMPLETED
Defective Atypical Protein Kinase C (PKC) Activation in Diabetes and Metabolic Syndrome nanCOMPLETED
Identification of Novel Targetable Kinases in SR-a GvHD nanCOMPLETED
NTRK 1,2,3 Rearrangements in Patients With Solid Tumors nanACTIVE_NOT_RECRUITING
Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma nanCOMPLETED
p-AKT Expression on Clinical Outcomes in Malignant Lymphoma nanCOMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia nanRECRUITING
Prospective Monocentric Clinical-biological Database nanRECRUITING
Epidemiology of Atherosclerosis nanCOMPLETED
K-RAS Oncogene Mutation in Patients With Advanced Non-Small Cell Lung Cancer Associated With Exposure to Wood Smoke and Tobacco Smoking: Therapeutic Implications nanCOMPLETED
Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAH nanCOMPLETED
A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK Study nanCOMPLETED
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
Intravenous Terbutaline in Severe Status Asthmaticus nanUNKNOWN
Possible Diagnostic Protein Markers in Schistosoma Related Bladder Diseases. nanNOT_YET_RECRUITING
A Retro-/Prospective, Non-interventional, Cohort Study in Adult Patients With Locally Advanced or Metastatic Tumors With a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion, Treated With Larotrectinib nanCOMPLETED
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a MARCKS binder may also engage these)

ProteinNameSimilarity
P26645 1.000 P26645 →
P30009 1.000 P30009 →
P16527 1.000 P16527 →
P12624 0.999 P12624 →
P80723 0.993 P80723 →
Q05175 0.989 Q05175 →
Q91XV3 0.986 Q91XV3 →
P80724 0.985 P80724 →
Q1RM09 0.981 Q1RM09 →
P23614 0.976 P23614 →
Q6PD99 0.975 Q6PD99 →
P05204 0.974 P05204 →
P07936 0.972 P07936 →
Q95K78 0.972 Q95K78 →
Q5IS67 0.971 Q5IS67 →
GAP43 Neuromodulin 0.971 landscape →
P06837 0.971 P06837 →
P02313 0.971 P02313 →
Q5R715 0.970 Q5R715 →
Q711A6 0.970 Q711A6 →
P80272 0.970 P80272 →
Q15651 0.970 Q15651 →
Q5ZIR5 0.969 Q5ZIR5 →
P06836 0.969 P06836 →
P02314 0.968 P02314 →
Q5NVP7 0.968 Q5NVP7 →
P12274 0.967 P12274 →
P18608 0.967 P18608 →
Q3ZBV4 0.966 Q3ZBV4 →
P05114 0.966 P05114 →